Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Total 13F shares
-
1,991,349
-
Share change
-
+222,805
-
Total reported value
-
$45,833,877
-
Price per share
-
$23.01
-
Number of holders
-
65
-
Value change
-
+$5,167,614
-
Number of buys
-
26
-
Number of sells
-
29
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q4 2023
As of 31 Dec 2023 ISHARES TR - GENOMICS IMMUN (IDNA) had 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,991,349 shares of stock of the company.
Largest 10 holders included JANE STREET GROUP, LLC, Wharton Business Group, LLC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, UBS Group AG, AMERIPRISE FINANCIAL INC, ROYAL BANK OF CANADA, LPL Financial LLC, Clearwater Capital Advisors, LLC, and COMMONWEALTH EQUITY SERVICES, LLC.
This table shows 65 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.